| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a gelatinous oral preparation having improved swallowability of an HMG-CoA reductase inhibitor, so-called statin compound, administered to the patient of hyperlipemia or hypercholesterolemia at the care site in the form of tablet, granule or liquid. <P>SOLUTION: The gelatinous drug composition free from disagreeable taste of statin compound, causing little syneresis in storage, having good shape retainability, easily takable from a container and having improved swallowability is composed of an HMG-CoA reductase inhibitor or its pharmacologically permissible salt, a gelatinizing agent, a polymeric compound, a buffering agent, a preservative, a sweetener, a base agent and water. <P>COPYRIGHT: (C)2007,JPO&INPIT |
